HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 3.85 CAD 1.32% Market Closed
Market Cap: 122.4m CAD
Have any thoughts about
HLS Therapeutics Inc?
Write Note

Wall Street
Price Targets

HLS Price Targets Summary
HLS Therapeutics Inc

Wall Street analysts forecast HLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HLS is 6.02 CAD with a low forecast of 3.54 CAD and a high forecast of 9.98 CAD.

Lowest
Price Target
3.54 CAD
8% Downside
Average
Price Target
6.02 CAD
56% Upside
Highest
Price Target
9.98 CAD
159% Upside
HLS Therapeutics Inc Competitors:
Price Targets
HSIC
Henry Schein Inc
7% Upside
9729
Tokai Corp (Gifu)
12% Upside
EBO
EBOS Group Ltd
8% Upside
FAGR
Fagron NV
30% Upside
GALE
Galenica AG
4% Upside
AMP
Amplifon SpA
25% Upside

Revenue
Forecast

Revenue Estimate
HLS Therapeutics Inc

The compound annual growth rate of HLS Therapeutics Inc's revenue for the next 4 years is 5%.

N/A
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
HLS Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Net Income
Forecast

Net Income Estimate
HLS Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HLS's stock price target?
Price Target
6.02 CAD

According to Wall Street analysts, the average 1-year price target for HLS is 6.02 CAD with a low forecast of 3.54 CAD and a high forecast of 9.98 CAD.

What is HLS Therapeutics Inc's Revenue forecast?
Projected CAGR
5%

The compound annual growth rate of HLS Therapeutics Inc's revenue for the next 4 years is 5%.

Back to Top